Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,694,888
-
Share change
-
+502,780
-
Total reported value
-
$1,739,831,314
-
Put/Call ratio
-
3.5%
-
Price per share
-
$118.41
-
Number of holders
-
86
-
Value change
-
+$59,909,606
-
Number of buys
-
38
-
Number of sells
-
46
Institutional Holders of CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) as of Q1 2021
As of 31 Mar 2021,
CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,694,888 shares.
The largest 10 holders included
HILLHOUSE CAPITAL ADVISORS, LTD., Temasek Holdings (Private) Ltd, Pentwater Capital Management LP, Athos Capital Ltd, BANK OF AMERICA CORP /DE/, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, Maso Capital Partners Ltd, Oasis Management Co Ltd., and ALPINE ASSOCIATES MANAGEMENT INC..
This page lists
86
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.